Locked pricing · Provider review
SnagRx review: $69 is a twelve-month price, $99 is the price
SnagRx advertises compounded semaglutide at $69 a month, which is the cheapest headline in this vertical. It is also the twelve-month plan rate. Month to month the same medication is $99, and the interesting question is how long you have to stay for the commitment to be worth making.
Published · Rates as published by SnagRx on that date · Editorial score 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Almost every discount in this category is a discount against time: pay less now, pay more later. SnagRx inverts it. The cheap rate is not an introductory offer that expires — it is a rate you buy by committing to twelve months of treatment up front, and the expensive rate is the one with no strings. That makes this a rare case where the arithmetic actually resolves rather than depending on an unpublished renewal price.
Twelve months of semaglutide on the plan is $828. Twelve months at the month-to-month rate is $1,188. The plan saves $360 a year — but only if you are still taking it in month twelve.
The short answer
- If you finish the year
- The plan wins by $360. $828 against $1,188 for identical medication, identical service and a rate that does not move when your dose does.
- If you stop early
- Month 9 is the break-even. Paying $99 month to month reaches $828 during month 9. Stop at or before month eight and the flexible rate was the cheaper purchase.
- The structural advantage
- The rate is locked at every dose. Titration does not re-price you, which is what makes a twelve-month total knowable here at all. In most of this vertical it is an estimate.
What SnagRx costs on each route
The table multiplies out the published rates. Unlike most tables of this kind it assumes nothing about dose escalation, because SnagRx states there is none to assume — the rate you enrol at is the rate at every dose.
| Route | Per month | 3 months | 6 months | 12 months |
|---|---|---|---|---|
| Semaglutide, 12-month plan | $69 | $207 | $414 | $828 |
| Semaglutide, month to month | $99 | $297 | $594 | $1,188 |
| Tirzepatide, 12-month plan | $119 | $357 | $714 | $1,428 |
| Tirzepatide, month to month | $149 | $447 | $894 | $1,788 |
Read the first two rows against each other rather than in isolation. The $30 monthly gap is what SnagRx charges for the right to leave, and $360 a year is a fair price for that right if there is any real chance you will use it. Discontinuation in the first months is common with these medications, usually over gastrointestinal side effects, and it is the single most likely reason a twelve-month plan turns out to have been the wrong purchase.
The comparison that matters is not SnagRx against its own two rates but SnagRx against a provider whose unconditional price matches its committed one. Embody is exactly that: $69 semaglutide and $119 tirzepatide with no commitment at all. We put the two side by side in the Embody vs SnagRx comparison — the twelve-month totals are identical, and everything rests on what you give up to reach them.
The locked rate is the product
Strip out the countdown timers and the struck-through list prices and what SnagRx is actually selling is predictability. Semaglutide titrates from 0.25 mg to 2.4 mg over several months and tirzepatide runs to 15 mg. A platform that prices per milligram can advertise a cheap starter month and bill a multiple of it by the time you reach a therapeutic dose — and you find out in month four, when switching means restarting titration somewhere else.
SnagRx charges one rate per medication for the duration and states it is locked for life. That is worth more than it sounds: it converts the twelve-month figure from an estimate into a number you can actually budget against on day one. In a vertical where most annual totals are educated guesses, that is the substantive claim on this page.
The tirzepatide tier is a different molecule, not a bigger service. $119 against $69 on the plan buys the dual GIP/GLP-1 agonist rather than more support — the intake, the shipping and the nursing access are the same on both. Whether the $600 annual premium is right for you is a question for the prescribing clinician.
Who is behind the prescription
SnagRx separates its three parts in public, which is unusual enough to be worth crediting. The prescriber is OpenLoop Health, a network of US-licensed clinicians covering 48 states, and SnagRx states plainly that its assessment does not create a doctor–patient relationship and that the clinician retains the prescribing decision. The dispensers are four named 503A pharmacies with published addresses.
Be precise about what that disclosure buys. A 503A pharmacy is licensed and inspected by its state board of pharmacy; it is not registered with the FDA as an outsourcing facility, which is the separate 503B category defined in the FDA’s compounding laws and policies. So naming a pharmacy is not federal verification — it is simply something you can check, which is more than an unnamed network offers. The compounded medication itself remains outside FDA approval either way.
What SnagRx does well
- $69 a month on the plan is the joint-lowest semaglutide rate in this vertical
- The rate is locked at every dose, so titration never re-prices you
- Names four US 503A partner pharmacies with addresses, and its clinician network
- States LegitScript certification — a credential you can verify independently
- Clinician review typically inside five hours; next-day temperature-controlled shipping
- Full refund if the prescription is declined, plus a six-month weight-loss guarantee
- No membership fee, no consultation fee, month-to-month available at a published rate
Where it falls short
- The advertised $69 and $119 rates require the twelve-month plan
- Month to month is $99 and $149 — a $30 monthly premium for flexibility
- Compounded only — no branded Ozempic, Wegovy, Mounjaro or Zepbound
- No coaching, nutrition curriculum or behavioural support of any kind
- Countdown-timer urgency marketing sits awkwardly on a prescription medication
- Discloses that some site content may be AI-generated and testimonial imagery may use models
- Direct-pay only, and the clinician network covers 48 states rather than 50
How the program runs
Four steps, and the timings are the notable part. SnagRx quotes a clinician decision inside five hours and next-day delivery after that, which puts a realistic start at two to three days from intake — quick even by the standards of a fast category.
- Complete the five-minute health qualifier and choose your medication
- An OpenLoop Health clinician reviews eligibility — typically within five hours, always within 24
- On approval, medication ships next-day by UPS or FedEx in temperature-controlled packaging
- Refills, dose adjustments and new prescriptions run through a secure patient portal
- If the clinician does not approve you, the payment is refunded in full
Who it suits
Someone who has taken a GLP-1 before, knows they tolerate it, and intends to stay on it for a year. That person should take the twelve-month plan without much deliberation: $828 for a year at a rate that cannot move is the strongest twelve-month position in this vertical, and the price lock removes the escalation risk that makes cheaper-looking rivals expensive by month six.
A first-time GLP-1 patient should take the $99 month-to-month rate instead, or compare against a provider whose unconditional rate is lower. Paying $30 a month for the option to walk away is cheap insurance when you do not yet know how the medication sits with you — and if you are still on it at month nine, you can move onto the plan then. For a flatly cheaper no-commitment alternative, Embody matches the committed rate with no plan attached; for a published-tier alternative at a duller headline, altRx is the closer structural comparison.
The verdict
SnagRx is a well-structured program wearing loud packaging. Underneath the countdown timers there is a locked rate, a named clinician network, four named 503A pharmacies, a verifiable compliance credential and two refund routes — a stronger disclosure record than most of this price tier manages, and the reason the score is not lower.
The mark against it is that the headline rate is conditional and the condition is not foregrounded. $69 is real, but it is a twelve-month price, and the honest month-to-month number is $99 — which is no longer the cheapest in the category. That is a marketing choice rather than a hidden fee, and it is the one thing to be clear about before you enrol.
Worth buying on the plan if you have done this before and expect to finish the year. Worth buying month to month if you have not. Worth comparing against the unconditional $69 alternative either way, because the twelve-month totals come out identical and only one of them asks you to commit.
SnagRx: common questions
How much does SnagRx cost?
Compounded semaglutide is $69 a month on the twelve-month plan or $99 month to month. Compounded tirzepatide is $119 on the plan or $149 month to month. Each price covers the medication, injection supplies, the clinician review and shipping — there is no membership fee and no separate consultation charge.
Do I have to commit to twelve months to get $69?
Yes. The $69 and $119 rates are the twelve-month plan prices; the no-commitment equivalents are $99 and $149. The gap is $30 a month on either molecule, so committing saves $360 over a year — but only if you finish the year.
When does the twelve-month plan pay for itself?
Month nine. Twelve months of semaglutide on the plan is $828; paying $99 month to month reaches $828 during month nine. Stay eight months or fewer and the flexible rate cost you less overall. Stay the full year and the plan saves $360. That single number is the whole decision, and it is not on the pricing page.
Does the price go up as my dose increases?
No, and this is the genuinely unusual part. SnagRx states the rate is locked flat at every dose for the life of treatment. Semaglutide titrates from 0.25 mg to 2.4 mg and tirzepatide up to 15 mg, and dose escalation is the normal way a cheap GLP-1 stops being cheap — a platform that prices per milligram can quote an attractive starter month and bill a multiple of it by the time you reach a therapeutic dose.
Is SnagRx FDA-approved?
No. SnagRx dispenses compounded semaglutide and tirzepatide, prepared by US 503A compounding pharmacies. Compounded preparations are not FDA-approved finished drug products, and a 503A pharmacy is licensed and inspected by its state board rather than registered with the FDA as an outsourcing facility. The active molecules are the same ones in Ozempic, Wegovy and Zepbound; the finished preparation has not been through FDA review.
Which pharmacies does SnagRx use?
SnagRx names four US partner pharmacies publicly, with addresses: RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Compounding Pharmacy (Bellmore, NY) and Triad Rx (Daphne, AL). Naming them is not federal verification, but it does mean you can look up a state licence for the facility compounding your medication before you pay — which most platforms in this category do not let you do.
Who writes the prescription?
OpenLoop Health, a network of US-licensed clinicians covering 48 states. SnagRx is explicit that completing its assessment does not create a doctor–patient relationship and that the OpenLoop clinician retains the prescribing decision. If that clinician does not approve you, SnagRx refunds in full.
How fast does SnagRx ship?
The intake takes about five minutes and SnagRx states clinician review is typically completed within five hours and always inside 24. Approved orders ship next-day by UPS or FedEx in discreet, temperature-controlled packaging. That is at the fast end of the category, though it is a commitment on the platform side rather than a guarantee you can enforce.
What is the weight loss guarantee?
SnagRx advertises a refund for patients who complete six months without significant weight loss, with terms applying, alongside the full refund if a prescription is declined. Read the terms before you rely on it — guarantees of this shape usually require documented adherence and a claim inside a specific window.
Does SnagRx take insurance?
No. It is direct-pay, which is standard for compounded GLP-1 programs — insurers rarely reimburse compounded preparations regardless of provider. There is no prior authorisation to fail, and equally nothing counts toward a deductible.
Keep comparing
See how the rest of the market prices the same treatment on the weight loss rankings, or read the head-to-head articles in the comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what SnagRx published on the date above and changes frequently. The $69 semaglutide and $119 tirzepatide rates require the twelve-month plan; the month-to-month rates are $99 and $149. Term totals are calculated from the published monthly rates; SnagRx states the rate is locked at every dose, so no escalation is assumed.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx, and does not sell treatment. Read our ranking methodology.